Loss of Beclin 1 Expression in Ovarian Cancer: A Potential Biomarker for Predicting Unfavorable Outcomes

Oncology Letters - Greece
doi 10.3892/ol.2017.7379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Circulating Biomarkers for Detection of Ovarian Cancer and Predicting Cancer Outcomes

British Journal of Cancer
Cancer ResearchOncology
2013English

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

Predicting Biomarkers for Ovarian Cancer Using Gene-Expression Microarrays

British Journal of Cancer
Cancer ResearchOncology
2004English

Nomogram for Predicting Gastric Cancer Recurrence Using Biomarker Gene Expression

European Journal of Surgical Oncology
MedicineOncologySurgery
2020English

A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer

Oncotarget
Oncology
2016English

Digit Ratio (2D:4D): A Potential Anatomical Biomarker for Predicting the Risk of Development of Polycystic Ovarian Syndrome

IOSR Journal of Dental and Medical Sciences
2016English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?

Biomarkers in Cancer
2015English

Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy